Humana Inc vs Lumen Technologies Inc — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Lumen Technologies Inc trades at $5.56 (market cap $6.10B). The key difference: Humana Inc is far larger — about 7.8× Lumen Technologies Inc's market cap, and Humana Inc pays a 0.89% dividend while Lumen Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Lumen Technologies Inc for 40 Days on average.
| HUM | LUMN | |
|---|---|---|
Market Cap | $47.61B | $6.10B |
Volume | 1,827,332 | 10,497,830 |
Sector | Health | Media |
52-Week High | $409.85 | $11.83 |
52-Week Low | $163.67 | $5.53 |
Typical Hold Time | 53 Days | 40 Days |
Enterprise Value | $54.97B | $17.72B |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
LUMN trades at $5.56, down 5.84% over 24 hours, with a bearish technical signal and negative net income margin of -8.65%. Recent earnings have been mixed, with a beat in Q2 2026 but a miss in Q1 2026. The company is focusing on AI-driven networking services, as highlighted by its Nasdaq listing move and new Intelligent Internet launch, aiming to capitalize on enterprise demand.
The outlook remains cautious due to persistent losses, high debt levels, and declining revenue, though cost management and strategic shifts toward AI and cloud services offer potential upside. Risks include execution challenges in legacy telecom decline and competitive pressures. Analyst consensus is largely hold or reduce, reflecting skepticism about near-term recovery.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →